Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 17Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uncommon Pathological Types of Lung Cancer 1Prostatic Neoplasms 1Liver Neoplasms 1Liver Cirrhosis 1Endometrial Neoplasms 1Chemotherapy-induced Thrombocytopenia 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Sorafenib 20lenvatinib 18Hepatectomy 17Blood Specimen Collection 12Immune Checkpoint Inhibitors 11Liver Transplantation 9atezolizumab 8Surgical Procedures, Operative 7Radiofrequency Ablation 7Observation 7Bevacizumab 6regorafenib 5gadolinium ethoxybenzyl DTPA 5sintilimab 4donafenib 4camrelizumab 4Radiotherapy 4Magnetic Resonance Spectroscopy 4tislelizumab 3spartalizumab 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Mass Spectrometry 3Immunohistochemistry 3Doxorubicin 3Angiogenesis Inhibitors 3toripalimab 2pembrolizumab 2entecavir 2apatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Hepatocellular × Injections × Clear all
NCT04682847 2024-01-31

Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Unknown
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡